TipRanks
Go Ultimate55% OFF

Clever Leaves Holdings (CLVR) AI Stock Analysis

242 Followers
CLVR

Clever Leaves Holdings

(Other OTC:CLVR)

Select Model
Rating:46Neutral
Action:N/A
Date:01/02/25

Clever Leaves Holdings faces substantial financial performance challenges, primarily due to ongoing net losses and cash flow issues despite some improvements in gross margins. The strong balance sheet offers some stability, but technical analysis and valuation scores are limited by lack of data and negative profitability. Earnings call insights are neutral, providing little additional impact.

Positive Factors
Improved Gross Profit MarginsThe improvement in gross profit margins indicates better cost management, which can enhance long-term profitability and competitiveness.
Negative Factors
Persistent Net LossesOngoing net losses and cash flow issues can hinder long-term sustainability and limit the ability to reinvest in business growth.

Clever Leaves Holdings (CLVR) vs. SPDR S&P 500 ETF (SPY)

-50%-40%-30%-20%-10%0%10%20%CLVR-45.00%SPY+12.53%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$19.65K
Dividend Yield
―
Average Volume (3M)
506
Price to Earnings (P/E)
0.0
Beta (1Y)
7169.16
Revenue Growth
―
EPS Growth
―
Country
US
Employees
296
Sector
Healthcare
Sector Strength
51
Industry
Drug Manufacturers - Specialty & Generic

Clever Leaves Holdings Business Overview & Revenue Model

Company Description

Clever Leaves Holdings Inc. is a company primarily focused on the cannabis sector. Its operations are structured into two distinct divisions: Cannabinoid and Non-Cannabinoid. The Cannabinoid segment oversees the global cultivation, extraction, manufa...

How the Company Makes Money

Clever Leaves Holdings generates revenue through its diversified business model, which includes the sale of cannabis extracts, such as CBD and THC oils, as well as dried flower and finished goods to pharmaceutical companies, consumer brands, and othe...

Clever Leaves Holdings Risk Analysis

Clever Leaves Holdings disclosed 49 risk factors in its most recent earnings report. Clever Leaves Holdings reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks
1.We effected a one-for-thirty reverse share split of our common shares (the "Reverse Share Split"), in August 2023.The Reverse Share Split may adversely impact the liquidity of our common shares and warrants and may not be effective in facilitating our efforts to maintain compliance with the continued listing requirements of Nasdaq.Q4, 2023
2.We may choose to delist our securities from Nasdaq and deregister under the Exchange Act, which could negatively affect the liquidity and trading prices of our common shares would result in substantially less disclosure about us and severely impair our ability to raise capital.Q4, 2023
3.We may not be able to obtain import permits in the destination countries or export permits in Colombia in a timely manner or of the required quantitiesQ4, 2023

Clever Leaves Holdings Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

CLVR against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
SNDLSNDL55Neutral$301.72M-7.03-5.50%―-2.49%32.03%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
TLRYTLRY46Neutral$373.90M-1.82-9.38%―15.93%93.85%
CLVRCLVR46Neutral$19.65K0.00-55.39%―――
IMCCIMCC37Underperform$1.30M-0.03841.81%―-11.91%-285.26%

* Healthcare Sector Average

Performance Comparison

-50%0%50%CLVRTLRYSNDLIMCCAKANDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
CLVR and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
CLVRClever Leaves Holdings, Inc.0.01-0.01-45.00%
TLRYTilray2.65-10.15-79.30%
SNDLSndl Inc.1.35-0.50-27.03%
IMCCIm Cannabis Corp0.72-39.18-98.19%
AKANAkanda Corp1.08-30.42-96.57%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Jan 02, 2025